Juvenile Idiopathic Arthritis
USMLE Step 1 trap: Confuses the evanescent fever-associated rash of systemic JIA with the fixed malar rash of SLE. Systemic JIA (Still disease) presents with a transient, evanescent salmon-colored rash that appears with fever spikes and fades between them.
Juvenile Idiopathic Arthritis (JIA) is the umbrella term for chronic arthritis starting before age 16 and lasting more than 6 weeks — and USMLE Step 1 tests it by punishing pattern-matching from adult rheumatology. Students assume inflammatory joint disease means RF-positive, or that eye involvement means a red painful eye. Neither is reliable here: JIA-associated uveitis is notoriously asymptomatic, destroying vision silently before any symptoms appear. It's a group of subtypes with distinct presentations, serologies, and complications, and the exam tests subtype recognition and the uveitis screening protocol.
The trickiest part of JIA is that it punishes pattern-matching from adult rheumatology. Students assume inflammatory joint disease means RF-positive, or that eye involvement means a red painful eye — neither is reliable here. Systemic JIA (Still disease) has a fever pattern and rash that look nothing like classic arthritis presentations. Oligoarticular JIA in a young ANA-positive girl can destroy her vision silently. USMLE Step 1 loves to test these counterintuitive features.
The exam tests JIA from two angles: subtype recognition (which patient fits which box) and management reasoning (why we screen even without symptoms). Both require understanding the underlying immunology and natural history, not just memorizing lists. Nail the evanescent rash of systemic JIA, know that oligoarticular ANA-positive is the uveitis risk group, and understand why RF-positive polyarticular JIA behaves like adult RA — those three anchors cover most of what gets tested.
Common misconceptions
What the exam tests
- Know the defining features of each JIA subtype: systemic (fever, salmon rash, organomegaly), oligoarticular (≤4 joints, ANA-positive, uveitis risk), polyarticular RF-negative (5+ joints, worse prognosis than oligo), polyarticular RF-positive (essentially juvenile RA, worst joint prognosis), enthesitis-related (HLA-B27, axial involvement), and psoriatic (nail pitting, dactylitis).
- Understand the treatment ladder for JIA (NSAIDs → methotrexate → biologics like TNF inhibitors) and know which subtype requires routine ophthalmologic slit-lamp screening regardless of eye symptoms.
Can you avoid these mistakes?
Related topics
See how your Anki deck covers this topic.
Upload your deck for a free audit →